{"id":"oral-micronized-progesterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Drowsiness or dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Abdominal bloating"},{"rate":null,"effect":"Mood changes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Progesterone is a naturally occurring steroid hormone that exerts its effects by binding to intracellular progesterone receptors (PR-A and PR-B). In the endometrium, it transforms the proliferative tissue into a secretory state, essential for implantation and maintenance of pregnancy. Micronization increases the bioavailability of the oral formulation, allowing adequate systemic absorption without first-pass hepatic metabolism.","oneSentence":"Oral micronized progesterone acts as a progestin that binds to progesterone receptors in the uterus and other reproductive tissues to regulate the menstrual cycle and support pregnancy.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:58:47.797Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Luteal phase support in assisted reproductive technology (ART)"},{"name":"Threatened or recurrent miscarriage prevention"},{"name":"Hormone replacement therapy in menopause"}]},"trialDetails":[{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT07496294","phase":"NA","title":"Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-04","conditions":"Menopausal Women, Menopausal Symptom Relief, Hormone Therapy","enrollment":200},{"nctId":"NCT06851754","phase":"PHASE3","title":"Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2025-07-17","conditions":"Premature Ovarian Insufficiency","enrollment":185},{"nctId":"NCT06497894","phase":"PHASE4","title":"No More Sleepless Nights in Perimenopause","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2026-01-01","conditions":"Insomnia, Menopause","enrollment":54},{"nctId":"NCT02633878","phase":"PHASE3","title":"Chinese Herbal Medicine (New \"Shoutai Wan\") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage","status":"COMPLETED","sponsor":"Heilongjiang University of Chinese Medicine","startDate":"2017-10-20","conditions":"Threatened Miscarriage","enrollment":1656},{"nctId":"NCT07010146","phase":"PHASE2","title":"Role of Estrogen on Skeletal Outcomes in FHA","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)","enrollment":150},{"nctId":"NCT06807580","phase":"PHASE2","title":"Progesterone in Gender Affirming Hormone Therapy Study","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-05-12","conditions":"Transgender Women","enrollment":40},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":"Embryo Transfer, Irregular Menstruation, Letrozole","enrollment":790},{"nctId":"NCT07173361","phase":"PHASE1","title":"Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-09-15","conditions":"Healthy Volunteers, Female, Progesterone","enrollment":20},{"nctId":"NCT06834594","phase":"PHASE4","title":"Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome","status":"RECRUITING","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2025-07-31","conditions":"Turner Syndrome, Primary Ovarian Insufficiency (Poi)","enrollment":40},{"nctId":"NCT03068910","phase":"EARLY_PHASE1","title":"Hyperandrogenemia and Altered Day-night LH Pulse Patterns","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2016-07-21","conditions":"Hyperandrogenism, Polycystic Ovary Syndrome, Puberty","enrollment":32},{"nctId":"NCT06856174","phase":"PHASE4","title":"Menopausal HT for Women Living With HIV (HoT)","status":"NOT_YET_RECRUITING","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2026-01-19","conditions":"HIV Infection, Menopause","enrollment":105},{"nctId":"NCT06975943","phase":"NA","title":"Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Soetomo General Hospital","startDate":"2024-01-01","conditions":"Pregnant Women, Pregnancies at Increased Risk of Preterm Birth","enrollment":48},{"nctId":"NCT00594217","phase":"PHASE1","title":"Determining How Quickly Progesterone Slows LH Pulse Frequency","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2007-11-29","conditions":"Normal, PCOS","enrollment":85},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT06763926","phase":"PHASE4","title":"Intranasal Nafarelin For Triggering Oocyte Maturation","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2025-03-15","conditions":"Fertility Disorders","enrollment":134},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT05903820","phase":"PHASE4","title":"Rhythmic Estradiol and Bone Health","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-19","conditions":"Osteoporosis Risk, Menopause","enrollment":48},{"nctId":"NCT06357442","phase":"","title":"Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-07-01","conditions":"Primary Ovarian Insufficiency, Hypogonadotropic Hypogonadism, Hormone Replacement Therapy","enrollment":34},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT06644794","phase":"PHASE3","title":"Progesterone-modified Natural Cycle for FET","status":"NOT_YET_RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2024-12-05","conditions":"Infertility, Female","enrollment":336},{"nctId":"NCT06616077","phase":"EARLY_PHASE1","title":"Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone","status":"COMPLETED","sponsor":"Reproductive Health Research Insritute, Chile","startDate":"2022-06-07","conditions":"Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone","enrollment":9},{"nctId":"NCT05899010","phase":"PHASE3","title":"MIcronized PROgesterone in Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-07-05","conditions":"Infertility","enrollment":1020},{"nctId":"NCT04758871","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2021-10-01","conditions":"Frozen Embryo Transfer, Hormone Replacement Therapy, Dydrogesterone","enrollment":150},{"nctId":"NCT05586724","phase":"PHASE3","title":"Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy","status":"RECRUITING","sponsor":"Angelica Lindén Hirschberg","startDate":"2022-03-15","conditions":"Menopausal Symptoms","enrollment":520},{"nctId":"NCT05128071","phase":"EARLY_PHASE1","title":"PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-02-04","conditions":"Methamphetamine-dependence, Postpartum Abstinence","enrollment":40},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":"Pre-Eclampsia, Frozen Embryo Transfer","enrollment":591},{"nctId":"NCT05168865","phase":"PHASE4","title":"Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.","status":"WITHDRAWN","sponsor":"Dubai Fertility Center","startDate":"2023-08-01","conditions":"Frozen Embryo Transfer, Polycystic Ovarian Disease, Letrozole","enrollment":""},{"nctId":"NCT01589081","phase":"NA","title":"Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect","status":"WITHDRAWN","sponsor":"Mclean Hospital","startDate":"2008-09","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT01589068","phase":"NA","title":"Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs","status":"WITHDRAWN","sponsor":"Mclean Hospital","startDate":"2007-01","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT01428089","phase":"PHASE1","title":"Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2011-03-11","conditions":"Polycystic Ovary Syndrome, Hyperandrogenism, Normal Puberty","enrollment":40},{"nctId":"NCT04597099","phase":"EARLY_PHASE1","title":"Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2022-10-26","conditions":"PCOS, Polycystic Ovary Syndrome","enrollment":10},{"nctId":"NCT04865029","phase":"PHASE2","title":"Estradiol and Progesterone in Hospitalized COVID-19 Patients","status":"TERMINATED","sponsor":"Tulane University","startDate":"2021-07-22","conditions":"Covid19","enrollment":10},{"nctId":"NCT05678192","phase":"PHASE1","title":"Effect of Menopausal Hormone Therapy on Immune System Parameters","status":"COMPLETED","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2021-12-01","conditions":"Last Period Not Earlier Than 6 Months Ago","enrollment":40},{"nctId":"NCT04108039","phase":"NA","title":"Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.","status":"COMPLETED","sponsor":"Fundacion Dexeus","startDate":"2019-09-25","conditions":"Infertility, IVF, Preimplantation Diagnosis","enrollment":44},{"nctId":"NCT03498313","phase":"PHASE4","title":"Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-07-27","conditions":"Suicidal Ideation","enrollment":60},{"nctId":"NCT04225221","phase":"PHASE2","title":"Neurobiology of Bulimia Nervosa","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-02-24","conditions":"Bulimia Nervosa","enrollment":10},{"nctId":"NCT01441635","phase":"PHASE2","title":"Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2011-09-08","conditions":"Heavy Uterine Bleeding, Uterine Fibroids","enrollment":271},{"nctId":"NCT00946192","phase":"PHASE3","title":"Fat Mediated Modulation of Reproductive and Endocrine Function in Young Athletes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-05","conditions":"Exercise-related Amenorrhea","enrollment":121},{"nctId":"NCT03003949","phase":"PHASE4","title":"The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-01-24","conditions":"Perimenopausal Disorder, Stress, Emotional","enrollment":82},{"nctId":"NCT03677336","phase":"PHASE4","title":"Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-05-01","conditions":"Infertility, Female, Infertility, Genital Diseases, Male","enrollment":30},{"nctId":"NCT01773772","phase":"PHASE1","title":"Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2005-02-08","conditions":"Female Puberty","enrollment":14},{"nctId":"NCT03832699","phase":"NA","title":"Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer","status":"UNKNOWN","sponsor":"Wolfson Medical Center","startDate":"2019-03-01","conditions":"ART","enrollment":100},{"nctId":"NCT03368898","phase":"","title":"Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding","status":"COMPLETED","sponsor":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","startDate":"2017-01-01","conditions":"Heavy Menstrual Bleeding","enrollment":104},{"nctId":"NCT04453332","phase":"NA","title":"Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2015-10-09","conditions":"Menopause, Hormone Replacement Therapy","enrollment":60},{"nctId":"NCT02779582","phase":"PHASE3","title":"Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2015-06","conditions":"Perimenopause, Menstrual Cramps","enrollment":59},{"nctId":"NCT03774745","phase":"PHASE1, PHASE2","title":"Blocking Mifepristone Action With Progesterone","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2019-02-11","conditions":"Pregnancy, Unwanted","enrollment":12},{"nctId":"NCT01464697","phase":"PHASE3","title":"Progesterone for Perimenopausal Night Sweats","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2011-10","conditions":"Hot Flushes, Night Sweats","enrollment":249},{"nctId":"NCT04124913","phase":"PHASE4","title":"Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Memorial Sisli Hospital, Istanbul","startDate":"2019-01-02","conditions":"Infertility, Female, Infertility, Male, Embryo Transfer","enrollment":140},{"nctId":"NCT01744574","phase":"NA","title":"Sex Differences, Hormones & Smoking Cessation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2012-12","conditions":"Tobacco Cessation","enrollment":216},{"nctId":"NCT02922348","phase":"PHASE3","title":"Hormone Replacement for Premature Ovarian Insufficiency","status":"WITHDRAWN","sponsor":"University of Pennsylvania","startDate":"2016-03-01","conditions":"Primary Ovarian Insufficiency","enrollment":""},{"nctId":"NCT01180296","phase":"PHASE3","title":"Oral Progesterone for Prevention of Preterm Birth","status":"COMPLETED","sponsor":"Fetal Medicine Foundation","startDate":"2006-11","conditions":"Preterm Birth","enrollment":36},{"nctId":"NCT03720847","phase":"PHASE4","title":"Effect of Perimenstrual Ovarian Steroid Supplementation on Perimenstrual Suicidality","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2016-12-31","conditions":"Suicidal Ideation","enrollment":30},{"nctId":"NCT02486757","phase":"EARLY_PHASE1","title":"Investigation of Female Reproductive Hormone Dynamics During Adolescence","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2015-04","conditions":"Menstruation Disturbances","enrollment":9},{"nctId":"NCT01602679","phase":"PHASE1","title":"Acute Effects of Progesterone on LH Pulses During the Follicular Phase (CRM006)","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2012-05","conditions":"Female Reproductive Physiology","enrollment":12},{"nctId":"NCT01809639","phase":"PHASE4","title":"Does Oral Micronized Progesterone Shorten Time of Symptoms From Concussion","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2013-06","conditions":"Concussion","enrollment":25},{"nctId":"NCT00805207","phase":"NA","title":"Sex Steroids, Sleep, and Metabolic Dysfunction in Women","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2007-09","conditions":"Polycystic Ovary Syndrome (PCOS), Obstructive Sleep Apnea, Obesity","enrollment":61},{"nctId":"NCT02272647","phase":"PHASE1","title":"Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-12","conditions":"Healthy","enrollment":47},{"nctId":"NCT03309735","phase":"","title":"Non-interventional Study of Therapy for Threatened Miscarriage","status":"COMPLETED","sponsor":"Besins Healthcare","startDate":"2017-10-16","conditions":"Threatened Miscarriage","enrollment":1241},{"nctId":"NCT01972464","phase":"PHASE2","title":"Progesterone for Smoking Relapse Prevention Following Delivery","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-11","conditions":"Tobacco Use Disorder","enrollment":41},{"nctId":"NCT01850030","phase":"PHASE3","title":"A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro Fertilization","status":"COMPLETED","sponsor":"Abbott","startDate":"2013-08","conditions":"Female Infertility","enrollment":1070},{"nctId":"NCT02989519","phase":"PHASE3","title":"Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor","status":"COMPLETED","sponsor":"Sanpasitthiprasong Hospital","startDate":"2015-08","conditions":"Preterm Delivery","enrollment":231},{"nctId":"NCT03267771","phase":"PHASE4","title":"Progesterone and Doppler in Recurrent Abortion","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-10-01","conditions":"Abortion in First Trimester","enrollment":50},{"nctId":"NCT01308814","phase":"PHASE2, PHASE3","title":"Perimenopausal Estrogen Replacement Therapy Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2010-10","conditions":"Perimenopause, Menopause, Depression","enrollment":172},{"nctId":"NCT02086032","phase":"NA","title":"The Effect of Different Types of Progestin on Sleeping of Menopausal Women","status":"COMPLETED","sponsor":"Chiang Mai University","startDate":"2014-01","conditions":"Menopausal and Postmenopausal Disorders","enrollment":100},{"nctId":"NCT01023178","phase":"NA","title":"Comparison of Transdermal and Oral Estrogens in Adolescent Girls With Ovarian Failure","status":"COMPLETED","sponsor":"Stanford University","startDate":"2007-02","conditions":"Ovarian Failure, Premature","enrollment":20},{"nctId":"NCT01798394","phase":"NA","title":"Progesterone & Postpartum Relapse to Smoking","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-06","conditions":"Tobacco Use Cessation, Tobacco Use Disorder","enrollment":46},{"nctId":"NCT01500863","phase":"PHASE4","title":"Endometrial Receptivity After GnRH Agonist Triggering","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2011-11","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":35},{"nctId":"NCT02571296","phase":"PHASE4","title":"The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth","status":"UNKNOWN","sponsor":"Ghamra Military Hospital","startDate":"2015-07","conditions":"Preterm Birth","enrollment":212},{"nctId":"NCT00632099","phase":"PHASE2, PHASE3","title":"Progesterone Treatment for Cocaine-dependent Women: A Pilot Study","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-02","conditions":"Cocaine Dependence","enrollment":21},{"nctId":"NCT01432028","phase":"NA","title":"Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women","status":"COMPLETED","sponsor":"Denusa Wiltgen","startDate":"2007-03","conditions":"Postmenopause","enrollment":90},{"nctId":"NCT01353846","phase":"PHASE4","title":"Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients","status":"UNKNOWN","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2011-05","conditions":"Infertility","enrollment":70},{"nctId":"NCT01123538","phase":"PHASE4","title":"Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2008-12","conditions":"Pharmacogenomics, Systems Biology","enrollment":40},{"nctId":"NCT00152438","phase":"PHASE2","title":"Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2005-09","conditions":"Menopause","enrollment":125}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"HOT FLUSH"},{"count":1,"reaction":"INSOMNIA"},{"count":1,"reaction":"MIDDLE INSOMNIA"},{"count":1,"reaction":"PRODUCT SUBSTITUTION ISSUE"}],"_approvalHistory":[],"publicationCount":120,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Prometrium","Utrogestan","Progesterone","progesterone","P4"],"phase":"marketed","status":"active","brandName":"Oral micronized progesterone","genericName":"Oral micronized progesterone","companyName":"University of British Columbia","companyId":"university-of-british-columbia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oral micronized progesterone acts as a progestin that binds to progesterone receptors in the uterus and other reproductive tissues to regulate the menstrual cycle and support pregnancy. Used for Luteal phase support in assisted reproductive technology (ART), Threatened or recurrent miscarriage prevention, Hormone replacement therapy in menopause.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}